Sign Up for a Free Account
  • Updated 05.14.2024
  • Released 06.30.2018
  • Expires For CME 05.14.2027

Hypoparathyroidism

Introduction

Overview

Hypoparathyroidism is an endocrine deficiency disease resulting from decreased function of the parathyroid glands, with underproduction of parathyroid hormone (PTH). Hypoparathyroidism typically presents with manifestations of hypocalcemia. Affected individuals can experience perioral and acral paresthesias, muscle cramps (especially carpopedal spasms), tetany, and seizures, but many also report fatigue, chronic headaches, insomnia, bone pain, and crampy abdominal pain. Symptomatic hypocalcemia can be a medical emergency requiring acute intravenous administration of calcium gluconate. Patients with hypoparathyroidism may also present with neurologic dysfunction related to ectopic brain calcification. Causes of hypoparathyroidism include surgery, autoimmune disorders, genetic diseases, hemochromatosis, magnesium deficiency, and idiopathic causes. The differential diagnosis includes hypomagnesemia, vitamin D deficiency, pseudohypoparathyroidism, and pseudopseudohypoparathyroidism. The primary goal of chronic management is to maintain calcium and phosphorus levels within acceptable limits. Current treatment options for chronic management include oral calcium, vitamin D, and thiazide diuretics. Teriparatide, a recombinant N-terminal fragment of PTH, has full biological activity; it is given by injection, and pump delivery emulates physiologic PTH replacement therapy.

Key points

• Hypoparathyroidism is an uncommon endocrine deficiency disease resulting from decreased function of the parathyroid glands, with underproduction of parathyroid hormone (PTH).

• Primary hypoparathyroidism results from a disorder of the parathyroid glands, whereas, in contrast, secondary hypoparathyroidism is a physiologic state in which PTH levels are low in response to a primary process that causes hypercalcemia.

• Hypoparathyroidism typically presents with manifestations of hypocalcemia because this interferes with normal muscle contraction and nerve conduction.

• Affected individuals can experience perioral and acral paresthesias, twitching in the facial muscles, muscle cramps (especially carpopedal spasms), and tetany, but many also report fatigue, chronic headaches, insomnia, bone pain, and crampy abdominal pain.

• Patients with hypoparathyroidism may present with hypocalcemic seizures or other neurologic dysfunction related to ectopic brain calcification.

• Causes of hypoparathyroidism include surgery, autoimmune disorders, genetic diseases, hemochromatosis, magnesium deficiency, and idiopathic causes.

• The differential diagnosis of hypoparathyroidism includes hypomagnesemia, vitamin D deficiency or hereditary insensitivity to this vitamin, pseudohypoparathyroidism, and pseudopseudohypoparathyroidism.

• In hypoparathyroidism, symptomatic hypocalcemia can be a medical emergency requiring acute intravenous administration of calcium gluconate.

• Hypoparathyroidism is the last endocrine deficiency disease for which treatment with the missing hormone is not standard therapy.

• Teriparatide, a recombinant N-terminal fragment of PTH (ie, PTH 1-34), has full biological activity; like insulin, it is given by injection, and pump delivery emulates physiologic PTH replacement therapy.

• The primary goals of chronic management are to maintain calcium and phosphorus levels within acceptable limits.

• Current treatment options for chronic management include oral calcium, vitamin D (including its metabolites and analogs), and thiazide diuretics.

Historical note and terminology

Hypoparathyroidism is an uncommon endocrine deficiency disease resulting from decreased function of the parathyroid glands, with underproduction of parathyroid hormone (PTH). This can lead to hypocalcemia and associated cramping, muscle twitching, or tetany. The condition can result from neck surgery (especially of the thyroid or parathyroid glands) or from immunologic, genetic, or other rare causes.

Primary hypoparathyroidism results from a disorder of the parathyroid glands. Secondary hypoparathyroidism is a physiologic state in which PTH levels are low in response to a primary process that causes hypercalcemia. This article will address primary hypoparathyroidism.

The history of our understanding of the parathyroid glands is detailed in the MedLink article, “Hypercalcemia.” In 1929 American endocrinologist Fuller Albright (1900-1969) and colleague Read McLane Ellsworth (1899-1970) diagnosed the first reported case of idiopathic hypoparathyroidism (05). Albright and colleagues later described pseudohypoparathyroidism and pseudopseudohypoparathyroidism (07; 06).

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

  • Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125